Tumor Necrosis Factor-α and Transforming Growth Factor-β Production by Isolated Mononuclear Cells from the Spinal Cords of Lewis Rats with Experimental Autoimmune Encephalomyelitis

Tohoku Journal of Experimental Medicine

Volumn 183, Issue 2, 1997, Pages 123-133

  Iwahashi, Teruaki ^a   Koh, Chang Sung ^a   Inoue, Atsushi ^a   Yanagisawa, Nobuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(TGF ); (TNF ); Enzyme linked immunospot (ELISPOT) assay; Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Transforming growth factor ; Tumor necrosis factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LEWIS RAT; MALE; MONONUCLEAR CELL; PATHOLOGY; RAT; SPINAL CORD;

ANIMALS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEUKOCYTES, MONONUCLEAR; MALE; RATS; RATS, INBRED LEW; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031243563     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.183.123     Document Type: Article

References (36)

1. Alvord, E.C., Jr., Kies, M.W. & Suckling, A.J. (1984) Progress in Clinical and Biological Research, edited by E.C. Alvord, Jr., M.W. Kies & A.J. Suckling, vol. 148, Alan R. Liss, New York, pp. 523-537.
2. Ando, D.G., Clayton, J., Kono, D., Urban, J.L. & Sercarz, E.E. (1989) Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol., 124, 132-143.
3. Chantry, D., Turner, M., Abney, E. & Feldmann, M. (1989) Modulation of cytokine production by transforming growth factor-β. J. Immunol., 142, 4295-4300.
4. Czerkinsky, C., Anderson, G., Ekre, H.P., Nilsson, L.A., Klareskog, L. & Ouchterlony, O. (1988) Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods, 110, 29-36.
5. Durum, S.K. & Oppenheim, J.J. (1993) Fundamental Immunology, edited by W.E. Paul, 3rd ed., Raven Press, New York, p. 801.
6. Espevik, T., Figari, I.S., Shalaby, M.R., Lackides, G.A., Lewis, G.D., Shepard, H.M. & Palladino, M.A., Jr. (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med., 166, 571-576.
7. Espevik, T.I., Figari, I.S., Ranges, G.E. & Palladino, M.A., Jr. (1988) Transforming growth factor β1(TGFβ1) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphkine-activated killer cell activity. J. Immunol., 140, 2312-2319.
8. Gamble, J.R. & Vadas, M.A. (1988) Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science, 242, 97-99.
9. Gamble, J.R. & Vadas, M.A. (1991) Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β1. J. Immunol., 146, 1149-1154.
10. Inoue, A., Koh, C.S., Yahikozawa, H., Yanagisawa, N., Yagita, H., Ishihara, Y. & Kim, B.S. (1996) The level of tumor necrosis factor-α producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol., 8, 1001-1008.
11. Irani, N.D. & Griffin, D.E. (1991) Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J. Immunol. Methods, 139, 223-231.
12. Johns, L.D., Babcock, G., Green, D., Freedman, M., Sriram, S. & Ransohoff, R.M. (1992) Transforming growth factor-β1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res., 585, 229-236.
13. Karpus, W.J. & Swanborg, R.H. (1991) CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β1. J. Immunol., 146, 1163-1168.
14. Koh, C.S. & Paterson, P.Y. (1987) Supression of clinical signs of cell transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with plasminogen activator inhibitor. Cell. Immunol. 107, 52-63.
15. Koh, C.S., Kwaan, H.C. & Paterson, P.Y. (1990) Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis. J. Neuroimmunol., 28, 189-200.
16. Lieberman, A.P., Pitha, P.M., Shin, H.S. & Shin, M.L. (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccaride or a neurotrophic virus. Proc. Natl. Acad. Sci. USA. 86, 6348-6352.
17. Lyons, R.M., Gentry, L.E., Purchio, A.F. & Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol., 110, 1362-1367.
18. McCarron, R.M., Wang, L., Racke, M.K., McFarlin, D.E. & Spatz, M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol., 43, 23-30.
19. Miyazono, K., Hellman, U., Wernstedt, C. & Heldin, C.H. (1988) Latent high molecular weight complex of transforming growth factor β1: Purification from human platelets and structural characterization. J. Biol. Chem., 263, 6407-6415.
20. Paterson, P.Y. (1978) Immunological Diseases, edited by M. Samter, N. Alexander, B. Rose, W.B. Sherman, D.W. Talmage & J.H. Vaughn, 3rd ed., Little Brown & Co., Boston, pp. 1400-1435.
21. Paterson, P.Y. (1980) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med., 111, 119-136.
22. Racke, M.K., Cannella, B., Albert, P.S., Sporn, M., Raine, C.S. & McFarlin, D.E. (1992) Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int. Immunol., 4, 615-620.
23. Ranges, G.E., Figari, I.S., Espevik, T. & Palladino, M.A. (1987) Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor-α. J. Exp. Med., 166, 991-998.
24. Robbins, D.S., Shirazi, Y. & Drysdal, B.E. (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol., 139, 2593-2597.
25. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Runnet. M.L., Padula, S.J. & Clark, R.B. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med., 172, 1193-1200.
26. Sato, Y., Tsuboi, R., Lyons, R., Moses, H. & Rifkin, D.B. (1990) Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J. Cell Biol., 111, 757-763.
27. Sawada, M., Kondo, N. & Marunouchi, T. (1989) Production of tumor necrosis factor-α by microglia and astrocytes in culture. Brain Res., 491, 394-397.
28. Selmaj, K.W. & Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol., 23, 339-346.
29. Selmaj, K.W. & Raine, C.S. (1995) Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology, 45, Suppl. 6, S44-48.
30. Selmaj, K.W., Raine, C.S. & Cross, A.H. (1991a) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol., 30, 694-700.
31. Selmaj, K., Raine, C.S., Canella, B. & Brosnan, C.F. (1991b) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis. J. Clin. Invest., 87, 949-954.
32. Sharief, K.M. & Hentges, R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med., 325, 467-472.
33. Skidmore, B.J., Stamnes, S., Townsend, K., Glasebrook, A.L., Sheehan, K.C.F., Schreider, R.D. & Chiller, J.M. (1989) Enumeration of cytokine-secreting cells at the single-cell level. Eur. J. Immunol., 19, 1591-1597.
34. Swanborg, R.H., Swiekosz, J.E. & Saieg, R.G. (1974) Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats. J. Immunol., 112, 594-600.
35. Wahl, S.M., McCartney-Francis, N. & Mergenhagen, S.E. (1989) Immunomodulatory role of transforming growth factor β. Immunol. Today, 10, 258-264.
36. Wakefield, L.M., Smith, D.M., Broz, S., Jackson, M., Levinson, A.D. & Sporn, M. (1989) Recombinant TGF-β1 is synthesized as a two component latent complex that shares some structural features with the native platelet TGF-β1 complex. Growth Factors, 1, 203-218.